The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.749. It has been cited 146 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.749
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 3U54CA260560-02S2
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
NIAID NIH HHS
Grant: 75N93019C00051
NIAID NIH HHS
Grant: HHSN272201400005C
NIAID NIH HHS
Grant: HHSN272201400008C
NCI NIH HHS
Grant: U54 CA260560
Fields of Study
Keywords
Sustainable Development Goals